Dual‐Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug‐Resistant Cancer Therapy

Abstract

In the initially published version of this article, Figure 8A contains misplaced images. The corrected Figure 8 is provided below. The correction does not affect the conclusions of the work. The authors apologize for any inconvenience or misunderstanding that this error might have caused. CorreCtion Figure 8. In vivo imaging of NPs biodistribution in mice bearing HCT8/ADR subcutaneous xenograft tumors. A) Whole body imaging from 0.5 to 24 h. B) In vivo radiant efficiency of the tumor sites. C) Imaging of major organs dissected from the mice. D) Imaging of tumors dissected from the mice. E) Ex vivo radiant efficiency of tumors.